A review of biological indicators of illicit drug use, practical considerations and clinical usefulness

Addiction

Volumn 94, Issue 9, 1999, Pages 1279-1298

  Wolff, K ^c   Farrell, M ^d   Marsden, J ^d   Monteiro, M G ^a   Ali, R ^b   Welch, S ^d   Strang, J ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Drug & Alcohol Services South Australia   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; ILLICIT DRUG; LYSERGIDE; METHADONE; OPIATE;

BLOOD ANALYSIS; DIAGNOSTIC ACCURACY; DRUG ABUSE; HAIR ANALYSIS; HUMAN; REVIEW; SALIVA ANALYSIS; SCREENING TEST; TOXICOLOGY; URINALYSIS;

EID: 0038139573     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1999.94912792.x     Document Type: Review

References (170)

1. ALLISON, M. & HUBBARD, R. I. (1985) Drug abuse treatment process: a review of the literature, International Journal of Addictions, 20, 1321-1345.
2. AMBRE, J. (1985) The urinary excretion of cocaine and metabolites in humans: a kinetic analysis of published data, Journal of Analytical Toxicology, 9, 241-245.
3. AMERICAN PSYCHIATRIC ASSOCIATION (1994) Diagnostic and Statistical Manual of Mental Disorders: DSM IV, 4th edn (Washington DC, American Psychiatric Association).
4. ARMBRUSTER, D. A. & KROLAK, J. M. (1992) Screening for drugs of abuse with the Roche ONTRAK assays, Journal of Analytical Toxicology, 18, 172-175.
5. ARMBRUSTER, D. A., HUBSTER, E. C., KAUFMAN, M. S. & RAMON, M. K. (1994) Cloned enzyme donor immunoassay (CEDIA) for drugs of abuse screening, Clinical Chemistry, 41, 92-98.
6. ASTLEY, S. J. & LITTLE, R. E. (1990) Maternal marijuana use during lactation and infant development at one year, Neurotoxicology & Teratology, 12, 161.
7. ATKINSON, H. C. & BEGG, E. J. (1990) Prediction of drug distribution into human milk from physicochemical characteristics, Clinical Pharmacokinetics, 18, 151-167.
8. BALABANOVA, S. & ALBERT, W. (1994) Accumulation and stability of drugs in hair, Archives of Criminology, 193, 100-112.
9. BEGG, E. J. & ATKINSON, H. C. (1991) Partitioning of drugs into human milk, Annals of Academic Medicine, Singapore, 20, 51-55.
10. BLANK, D. L. & KIDWELL, D. A. (1993) External contamination of hair by cocaine: an issue in forensic interpretation, Forensic Science International, 63, 145-156; discussion, 157-160.
11. BLANK, D. L. & KIDWELL, D. A. (1995) Decontamination procedures for drugs of abuse in hair: are they sufficient? Forensic Science International, 70, 13-38.
12. BOGUSZ, M. J., ALTHOFF, H., ERKENS, M., MAIER, R. D. & HOFMANN, R. (1995) Internally concealed cocaine: analytical and diagnostic aspects, Journal of Forensic Science, 40, 811-815.
13. BRAITHWAITE, R. A., JARVIE, D. R., MINTY, P. S. B., SIMPSON, D. & WIDDOP, B. (1995) Screening for drugs of abuse (I): opiates, amphetamines and cocaine, Annals of Clinical Biochemistry, 32, 123-153.
14. BREWER, C. (1993) Hair analysis as a tool for monitoring and managing patients on methadone maintenance. A discussion, Forensic Science International, 63, 277-283.
15. BURNETT, D., LADER, S., RICHENS, A. et al. (1990) A survey of drugs of abuse testing by clinical laboratories in the United Kingdom, Annals of Clinical Biochemistry, 27, 213-222.
16. CASSANI, M. & SPIEHLER, W. (1993) Analytical requirements, perspectives and limits of immunological methods for drugs in hair, Forensic Science International, 63, 175-184.
17. CHASNOFF, I. J., LEWIS, D. E. & SQUIRES, L. (1987) Cocaine intoxication in a breast-fed infant, Pediatrics, 80, 836.
18. CHIAROTTI, M. (1993) Overview on extraction procedures, Forensic Science International, 63, 161-170.
19. CIRIMELE, V., KINTZ, P. & MANGIN, P. (1995) Detection and quantification of lorazepam in human hair by GC-MS/NCI in a case of traffic accident, International Journal of Legal Medicine, 108, 265-267.
20. CODY, J. J. & SCHWARZHOFF, R. (1993) Interpretation of methamphetamine and amphetamine enantiomer data, Journal of Analytical Toxicology, 17, 321-325.
21. CONE, E. J., JUFER, R., DARWIN, W. D. & NEEDLEMAN, S. B. (1996) Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin, Journal of Analytical Toxicology, 20, 379-392.
22. CONE, E. J. (1996) Mechanisms of drug incorporation into hair, Therapeutic Drug Monitoring, 18, 438-443.
23. CONE, E. J. (1993) Saliva testing for drugs of abuse, Annals of the New York Academy of Science, 694, 91-127.
24. CONE, E. J., DARWIN, W. D. & WANG, W. L. (1993) The occurrence of cocaine, heroin and metabolites in hair of drag abusers, Forensic Science International, 63, 55-68.
25. CONE, E. J., WELCH, P., PAUL, B. D. & MITCHELL, J. M. (1991) Forensic drug testing for opiates III. Urinary excretion rates of morphine and codeine following codeine administration, Journal of Analytical Toxicology, 15, 161-166.
26. CONE, E. J., DICKERSON, S., PAUL, B. D. & MITCHELL, J. M. (1992) Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays, Journal of Annals of Toxicology, 16, 72-78.
27. CONE, E. J., HILLSGROVE, M. J., JENKINS, A. J., KEENAN, R. M. & DARWIN, W. D. (1994) Sweat testing for heroin, cocaine, and metabolites, Journal of Analytical Toxicology, 18, 298-305.
28. COWAN, J. M. JR., WEATHERMON, A., MCCUTCHEON, J. R. & OLIVER, R. D. (1996) Determination of volume of distribution for ethanol in male and female subjects, Journal of Analytical Toxicology, 20, 287-290.
29. CUI, J. F., LI, L., CUI, K. K. et al. (1993) Separation and identification of stimulants and their metabolites, Yao Hsueh Hsueh Pao, 28, 455-463.
30. CURVALL, M., VALA, E. K., ENZELL, C. R. & WAHREN, J. (1990) Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in the body fluids of non-smokers given intravenous infusions of nicotine, Clinical Pharmacology & Therapeutics, 47, 42-49.
31. DE LA TORRE, R., SEGURA, J., DE ZEEUW, R. & WILLIAMS, J. (1997) Recommendations for the reliable detection of illicit drugs in urine in the European Union with special attention to the workplace, Annals of Clinical Biochemistry, 34, 339-344.
32. DE VOS, J. W., GEERLINGS, P. J., VAN DEN BRINK, W., UFKES, J. G. R. & VAN Il GENBURG, H. (1995) Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts, European Journal of Clinical Pharmacology, 48, 361-366.
33. DE ZEEUW, R. A. (1980) Drugs in saliva, in: REID, E. (Ed.) Trace Organic Sample Handling, vol 10, pp. 177-187 (New York, Ellis Horwood, John Wiley & Sons).
34. DEGEL, F. & PAULUS, N. (1996) Documentation of European drugs with standardised TLC systems, in: SUNSHINE, I. (Ed.) Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology, pp. 655-662 (New York, Marcel Dekker, Inc.)
35. DEMEDTS, P., WAUTERS, A., FRANCK, F. & NEELS, H. (1994) Evaluation of the REMEDi drug rofiling system, European Journal of Clinical Chemistry & Clinical Biochemistry, 32, 409-417.
36. DI GREGORIO, G. J., FERKO, A. P., BARBIEN, E. J. et al. (1994) Determination of cocaine usage in pregnant women by urinary EMIT drug screen and GC-MS analyses, Journal of Analytical Toxicology, 18, 247-250.
37. DIAMOND, F. X., VICKERY, W. E. & DE KANEL, J. (1996) Extraction of benzoylecgonine (cocaine metabolite) and opiates (codeine and morphine) from urine samples using the Zymark Rapid Trace, Journal of Analytical Toxicology, 20, 587-591.
38. DICKSON, P. H., LIND, A., STUDTS, P., NIPPER, H. C., MAKOID, M. & THERKILDSEN, D. (1994) The routine analysis of breast milk for drugs in a clinical toxicology laboratory, Journal of Forensic Sciences, 39, 207-214.
39. DROBITCH, R. K. & SVENSSON, C. K. (1992) Therapeutic drug monitoring in saliva. An update, Clinical Pharmacokinetics, 23, 365-379.
40. DUPONT, R. L. & BAUMGARTNER, W. A. (1995) Drug testing by urine and hair analysis: complementary features and scientific issues, Forensic Science International, 70, 63-76.
41. EADIE, M. J. (1995) The role of therapeutic drug monitoring in improving the cost effectiveness of anticonvulsant therapy, Clinical Pharmacokinetics, 29, 29-35.
42. EAP, C. B., FINKBEINER, T., GASTPAR, M., SCHERBAUM, N., POWELL, K. & BAUMANN, P. (1996) Replacement of (R) methadone by a double dose of (R)(S) methadone in addicts: evidence of adaptive changes in methadone pharmacokinetics, European Journal of Clinical Pharmacology, 50, 385-39.
43. EDINBORO, L. E. & POKLIS, A. (1994) Detection of benzodiazepines and tribenzazolams by TRIAGE: confirmation by solid-phase extraction utilizing SPEC.3ML.MP3 microcolumns and GC-MS, Journal of Analytical Toxicology, 18, 312-316.
44. ELIOPOULOS, C., KLEIN, J., CHITAYAT, D., GREENWALD, M. & KOREN, G. (1996) Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking, Clinical Investigations in Medicine, 19, 231-242.
45. FEDERAL REGISTER (1994) Mandatory guidelines for federal workplace drug testing programs, Substance Abuse & Mental Health Services Administration, DHHS, Rockville, MD, notices 59; 29908-29931.
46. FEDERAL REGISTER (1997) Mandatory guidelines for federal workplace drug testing programs, Substance Abuse & Mental Health Services Administration, DHHS, Rockville, MD, notices 62; 51118-51119.
47. FERRARA, S. D., TEDESCHI, I., FRISON, G. et al. (1994) Drugs of abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques, Journal of Analytical Toxicology, 18, 278-291.
48. GEORGE, S. & BRAITHWAITE, R. A. (1995) A preliminary evaluation of five rapid detection kits for onsite drugs of abuse screening, Addiction, 90, 227-232.
49. GIACOIA, G. P. & CATZ, C. S. (1979) Drugs and pollutants in breast milk, Clinical Perinatology, 6, 181.
50. GORODISCHER, R., BURTIN, P., HWANG, P., LEVINE, M. & KOREN, G. (1994) Saliva versus blood sampling for therapeutic drug monitoring in children: patient and parental preferences and an economic analysis, Therapeutic Drug Monitoring, 16, 437-443.
51. GOUGH, T. A. (1991) The Analysis of Drugs of Abuse (Chichester, John Wiley & Sons).
52. GOULLE, J. P. & KINTZ, P. (1996) A new tool for biological study: hair analysis. Value in medical practice, Review of the Medical Intern, 17, 826-835.
53. GROTE, C. & PAWLISZYN, J. (1997) Solid-phase microextraction for the analysis of human breath, Annals of Chemistry, 69, 589-596.
54. GRUNBERGER, J., LINZMAYER, L., GRUNBERGER, M. & SALETI, B. (1992) Pupillometry in clinical psycho-physiological diagnostics, Israeli Journal of Psychiatry of Related Science, 100-113.
55. GUITTON, J., DAVID, O., MIALON, A. & MANCHON, M. (1993) Evaluation of an automated liquid chromatograph permitting toxicologic screening of biological fluids, Annals of Clinical Biology-Paris, 51, 611-617.
56. GYGI, S. P., JOSEPH, R. E. JR, CONE, E. J., WILKINS, D. G. & ROLLINS, D. E. (1996) Incorporation of codeine and metabolites into hair. Role of pigmentation, Drug Metabolism and Disposition, 24, 495-501.
57. HAECKEL, R. & HANECKE, P. (1996) Application of saliva for drug monitoring. An in-vivo model for transmembrane transport, European Journal of Chemistry and Clinical Biochemistry, 34, 171-191.
58. HAILER, M., GLIENKE, Y., SCHWAB, I. M. & VON MEYER, L. (1995) Modification and evaluation of Abuscreen Online assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u., Cannabinoid, Journal of Analytical Toxicology, 19, 99-103.
59. HANKS, G. W. (1987) The clinical usefulness of agonist-antagonist opioid analgesics in chronic pain, Drug and Alcohol Dependence, 20, 339-347.
60. HANNAK, D., SCHARBERT F. & KATTERMANN, R. (1996) Stepwise binary gradient high-performance liquid chromatographic system for routine drug monitoring, Journal of Chromatography A, 728, 307-310.
61. HANSELER, E. & KELLER, H. (1994) Sensitivity and specificity of cocaine metabolite screening in view of the analytical performance of a fluorescence polarisation immunoassay, European Journal of Chemistry and Clinical Biochemistry, 32, 865-871.
62. HARKEY, M. R. (1993) Anatomy and physiology of hair, Forensic Science International, 63, 9-18.
63. HAWKS, R. L. & CHIANG, C. N. (1986) Examples of specific drug assays, NIDA - Research Monographs, 73, 84-112.
64. HENDERSON, G. L. & WILSON, B. K. (1973) Excretion of methadone and metabolites in human sweat, Research Communications in Chemical Pathology Pharmacology, 5, 1.
65. HENDERSON, G. L. (1993) Mechanisms of drug incorporation into hair, Forensic Science International, 63, 19-29.
66. HOLD, K. M., DE BOER, D., ZUIDEMA, J. & MAES, R. A. (1995) Evaluation of the Salivette as sampling device for monitoring beta-adrenoceptor blocking drugs in saliva, Journal of Chromatography B: Biomedical Applications, 66, 103-110.
67. HUESTIS, M. A. & CONE, E. J. (1998) Alternative testing matrices, in: KARCH, S. (Ed.) Drug Abuse Handbook, pp. 799-857 (London, CRC Press).
68. HUESTIS, M. A. (1996) Judicial acceptance of hair tests for substances of abuse in the United States courts: scientific, forensic, and ethical aspects, Therapeutic Drug Monitoring, 18, 456-459.
69. HUNT, C. A. & JONES, R. T. (1980) Tolerance and deposition of tetrahydrocannabinol in man, Journal Pharmacology & Experimental Therapeutics, 215, 35-44.
70. ISHIYAMA, I., NAGAI, T., KOMURO, E., MOMOSE, T. & AKIMORI, N. (1979) The significance of drug analysis of sweat in respect of rapid screening for drug abuse, Zeitschrift fur Rechtsmedizin [Journal of Legal Medicine], 82, 251-256.
71. JENKINS, A. J., DARWIN, W. D., HUESTIS, M. A., CONE, E. J. & MITCHELL, J. M. (1995) Validity testing of the accuPINCH THC test, Journal of Analytical Toxicology, 19, 5-12.
72. JENKINS, A. J., MILLS, L. C., DARWIN, W. D., HUESTIS, M. A., CONE, E. J. & MITCHELL, J. M. (1993) Validity testing of the EZ-SCREEN cannabinoid test, Journal of Analytical Toxicology, 17, 292-298.
73. JENKINS, A. J., OYLER, J. M. & CONE, E. J. (1995) Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma, Journal of Analytical Toxicology, 19, 359-363.
74. JOSEPH, R. E. JR, SU, T. P. & CONE, E. J. (1996) In vitro binding studies of drugs to hair: influence of melanin and lipids on cocaine binding to Caucasoid and Africoid hair, Journal of Analytical Toxicology, 20, 338-344.
75. JURADO, C., GIMENEZ, M. P., MENENDEZ, M. & REPETTO, M. (1995) Simultaneous quantification of opiates, cocaine and cannabinoids in hair, Forensic Science International, 70, 165-174.
76. JURADO, G., MENENDEZ, M., REPETTO, M., KINTZ, P., CIRIMELE, V. & MANGIN, P. (1996) Hair testing for cannabis in Spain and France: is there a difference in consumption? Journal of Analytical Toxicology 20, 111-115.
77. KALASINSKY, K. S., MAGLUILO, J. JR & SCHAEFER, T. (1994) Study of drug distribution in hair by infrared microscopy visualization, Journal of Analytical Toxicology, 18, 337-341.
78. KAPUR, B. M. (1993) Drug-testing methods and clinical interpretations of test results, Bulletin of Narcotics, 45, 115-154.
79. KARCH, S. B. (1996) The Pathology of Drug Abuse, 2nd edn, pp. 34-39 (Florida, CRC Press).
80. KARLSSON, L. & STROM, M. (1988) Laboratory evaluation of the TDX assay for detection of cannabionoids in urine from prison inmates, Journal of Analytical Toxicology, 12, 319-321.
81. KIDWELL, D. A. (1992) Discussion: caveats in testing for drugs of abuse, in: KILBEY, M. & ASGHAR, K. (Eds) Methodological Issues in Edpidemiological prevention and Treatment Research on Drug-Exposed Women and their Children, NIDA Research Monographs series 117, pp. 98-120 (Rockville, MD, NIDA).
82. KINTZ, P. (1995) Inter-laboratory comparison of quantitative determinations of drug in hair samples, Forensic Science International, 70, 105-109.
83. KINTZ, P. (1996) Drug testing in addicts: a comparison between urine, sweat, and hair, Therapeutic Drug Monitoring, 18, 450-455.
84. KINTZ, P. & MANGIN, P. (1993) Evidence of gestational heroin or nicotine exposure by analysis of fetal hair, Forensic Science International, 63, 99-104.
85. KINTZ, P., CIRIMELE, V. & MANGIN, P. (1995) Testing human hair for cannabis. II. Identification of THCCOOH by GC-MS-NCI as a unique proof, Journal of Forensic Science, 40, 619-622.
86. KINTZ, P., CIRIMELE, V., EDEL, Y., JAMEY, C. & MANGIN, P. (1994) Hair analysis for buprenorphine and its dealkylated metabolite by RIA and confirmation by LC/ECD, Journal of Forensic Science, 39, 1497-1503.
87. KINTZ, P., TRACQUI, A. & MANGIN, P. (1992) Detection of drugs in human hair for clinical and forensic applications, International Journal of Legal Medicine, 105, 1-4.
88. KLEIN, J., FORMAN, R., ELIOPOULOS, C. & KOREN, G. (1994) A method for simultaneous measurement of cocaine and nicotine in neonatal hair, Therapeutic Drug Monitoring, 16, 67-70.
89. KOCH, T. R., RAGLIN, R. L., KIRK, S. & BRUNI, J. F. (1994) Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse, Journal of Analytical Toxicology, 18, 168-172.
90. KWONG, T. C. & RYAN, R. M. (1997) Detection of intrauterine illicit drug exposure by new-born drug testing, National Academy of Clinical Biochemistry, Clinical Chemistry, 43, 235-242.
91. LAW, B., MASON, P. A., MOFFAT, A. C., GLEADLE, R. I. & KING, L. J. (1984) Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin, Journal of Pharmacy and Pharmacology, 36, 289-294.
92. LEBEDEVS, T. H., WOJNAR-HORTON, R. E., YAPP, P., ROBERTS, M. J., DUSCI, L. J., HACKETT, L. P. & ILETT, K. L. (1992) Excretion of temazepam in breast milk, British Journal of Clinical Pharmacology, 33, 204-209.
93. 9-Tetrahydrocannabinol: metabolism and disposition in long term marijuana smokers, Science, 178, 72-74.
94. LEWIS, D. E., MOORE, C. M., LEIKIN, J. & KOLLER, A (1995) Meconium analysis for cocaine: a validation study and comparison with paired urine analysis, Journal of Analytical Toxicology, 19, 148-150.
95. LEWIS, D., MOORE, C., MORRISSEY, P. & LEIKIN, J. (1997) Determination of drug exposure using hair: application to child protective cases, Forensic Science International, 84, 123-128.
96. LILLSUNDE, P., MICHELSON, L., FORSSTRUM, T. et al. (1996) Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety, Forensic Science International, 77, 191-210.
97. LOIMER, N., HOFMANN, P. & CHAUDRY, H. R. (1992) Nasal administration of naloxone for detection of opiate dependence, Journal of Psychiatric Research, 26, 39-43.
98. LUCK, W. & NAU, H. (1984) Nicotine and Cotinine concentrations in serum and milk of nursing smokers, British Journal of Clinical Pharmacology, 18, 9.
99. MANOLIS, A., MCBURNEY, L. J. & BOBBIE, B. A. (1983) The detection of delta-9-tetrahydro-cannabinol in the breath of human subjects, Clinical Biochemistry, 16, 229-232.
100. MARSH, A. (1997) Hair analysis for drugs of abuse, Syva Drug Monitor, 2, 1-4.
101. MARSH, A., EVANS, M. B. & STRANG, J. (1995) Radioimmunoassay of drugs of abuse in hair. Part 2: the determination of methadone in hair of known drug users, Journal of Pharmacology and Analytical Biomedicine, 13, 829-839.
102. MARTIN, J. C., BARR, H. M., MARTIN, D. C. & STREISSGUTH, A. P. (1996) Neonatal neurobehavioral outcome following prenatal exposure to cocaine, Neurotoxicology and Teratology, 18, 617-625.
103. MCCARTHY, J. (1994) Quantitative urine drug monitoring in metadone programs: potential clinical uses, Journal of Psychoactive Drugs, 26, 199-206.
104. MEADWAY, C., GEORGE, S. & BRAITHWAITE, R. (1998) Opiate concentrations following ingestion of poppy seed products-evidence for "the poppy seed defence", Forensic Science International, 96, 29-38.
105. MIECZKOWSKI, T. & NEWELL, R. (1993) An evaluation of patterns of racial bias in hair assays for cocaine: black and white arrestees compared, Forensic Science International, 63, 85-98.
106. MIYAZAWA, N. & UEMATSU, T. (1992) Analysis of ofloxacin in hair as a measure of hair growth and as a time marker for hair analysis, Therapeutic Drug Monitoring, 14, 525-528.
107. MOELLER, M. R. (1992) Drug detection in hair by chromatographic procedures, Journal of Chromatography, 580, 125-134.
108. MOELLER, M. R. (1996) Hair analysis as evidence in forensic cases. Therapeutic Drug Monitoring, 18, 444-449.
109. MOELLER, M. R. FEY, P. & WENNIG, R. (1993) Simultaneous determination of drugs of abuse (opiates, cocaine and amphetamine) in human hair by GC/MS and its application to a methadone treatment program, Forensic Science International, 63, 185-206.
110. MOFFAT, A. C., JACKSON, J. V., MOSS, M. S. & WIDDOP (1986) Clarks Isolation and Identification of Drugs (UK, The Pharmaceutical Press).
111. MOORE, C., DEMPSEY, D., DEITERMANN, D., LEWIS, D. & LEIKIN, J. (1996) Foetal cocaine exposure: analysis of vernix caseosa, Journal of Analytical Toxicology, 20, 509-511.
112. MOORE, C., LEWIS, D. & LEIKIN, J. (1995) False-positive and false-negative rates in meconium drug testing, Clinical Chemistry, 41, 1614-1616.
113. MOORE, C., LEWIS, D., BECKER, J. & LEIKIN, J. (1996) The determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in meconium, Journal of Analytical Toxicology, 20, 50-51.
114. MUCKLOW, J., BENDING, M. R., KAHN, G. C. & DOLLERY, C. T. (1978) Drug concentration in saliva, Clinical Pharmacology Therapeutics, 24, 563-569.
115. NAKAHARA, Y. & KIKURA, R. (1996) Hair analysis for drugs of abuse. XIII. Effect of structural factors on incorporation of drugs into hair: the incorporation rates of amphetamine analogs, Archives of Toxicology, 70, 841-849.
116. NAKAHARA, Y. & KIKURA, R. (1994) Hair analysis for drugs of abuse. VII. The incorporation rates of cocaine, benzoylecgonine and ecgonine methyl ester into rat hair and hydrolysis of cocaine in rat hair, Archives of Toxicology, 68, 54-59.
117. NAKAHARA, Y., SHIMAMINE, M. & TAKAHASHI, K. (1992) Hair analysis for drugs of abuse. III. Movement and stability of methoxyphenamine (as a model compound of methamphetamine) along hair shaft with hair growth, Journal of Analytical Toxicology, 16, 253-257.
118. NAKAHARA, Y., TAKAHASHI, K. & KIKURA, R. (1995) Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rates into hair, Biological Pharmacology Bulletin, 18, 1223-1227.
119. NILSSON, M. I., WIDERLOF, E. & MERESAAR, U. (1982) Effect of urinary pH on the disposition of methadone in man, European Journal of Clinical Pharmacology, 22, 337-342.
120. OFFIDANI, C., STRANO-ROSSI, S. & CHIAROTTI, M. (1993) Improved enzymatic hydrolysis of hair, Forensic Science International, 63, 171-174.
121. OSTREA, E. M., JR., ROMERO, A., KNAPP, D. K., OSTREA, A. R., LUCENA, J. E. & UTARNACHITT, R. B. (1994) Post-mortem drug analysis of meconium in early-gestation human foetuses exposed to cocaine: clinical implications, Journal of Paediatrics, 124, 477-479.
122. PALFREY, S. & LABIB, M. (1996) A simple HPLC method for the separation of amphetamine isomers in urine and its application in differentiating between "street" amphetamine and prescribed D amphetamine, Annals of Clinical Biochemistry, 33, 344-346.
123. PEAT, M. & DAVIS, A. E. (1998) Workplace testing: Analytical considerations and approaches for drugs, in: KARCH, S.B. (Ed.) Drug Abuse Handbook, p. 753 (New York, CRC Press).
124. PICHINI, S., ALTIERI, I., ZUCCARO, P. & PACIFICI, R. (1996) Drug monitoring in non-conventional biological fluids and matrices, Clinical Pharmacokinetics, 30, 211-228.
125. POND, S. M., KREEK, M. J., TONG, T. G., RAGHUNATH, J. & BENOWITZ, N. L. (1985) Altered methadone pharmacokinetics in methadone-maintained pregnant women, Journal of Pharmacology & Experimental Therapeutics, 233, 1-6.
126. POTSCH, L. & SKOPP, G. (1996) Stability of opiates in hair fibres after exposure to cosmetic treatment, Forensic Science International, 81, 95-102.
127. REISNER, S. H., EISENBERG, N. H. & HAUSER, G. J. (1983) Maternal medications and breast-feeding, Developmental Pharmacology & Therapeutics, 6, 285.
128. ROBIEUX, I., KOREN, G., VANDENBERGH, H. & SCHNEIDERMAN, J. (1990) Morphine excretion in breast milk and resultant exposure of a nursing infant, Journal Toxicology & Clinical Toxicology, 28, 365-370.
129. ROLLINS, D. E., WILKINS, D. G. & KRUEGER, G. (1995) Models for studying the cellular processes and barriers to the incorporation of drugs into hair, NIDA Research Monographs, 154, 235-244.
130. RYAN, R. M., WAGNER, C. L., SCHULTZ, J. M. et al. (1994) Meconium analysis for improved identification of infants exposed to cocaine in utero, Journal of Paediatrics, 125, 435-440.
131. SACHS, H. & RAFF, I. (1993) Comparison of quantitative results of drugs in human hair by GC/MS, Forensic Science International, 63, 207-216.
132. SACHS, H. (1995) Theoretical limits of the evaluation of drug concentrations in hair due to irregular hair growth, Forensic Science International, 70, 53-61.
133. SACHS, H. DENK, R. & RAFF, I. (1993) Determination of dihydrocodeine in hair of opiate addicts by GC/MS, International Journal of Legal Medicine, 105, 247-250.
134. SAMPERIZ, S., MILLET, V., ARDITTI, J. et al. (1996) Value of toxicological research in new-born infants of addicted mothers by the study of several samples (urine, meconium, hair), Archives of Paediatrics, 3, 440-444.
135. SCHRAMM, W., CRAIG, P. A., SMITH, R. H. & BERGER, G. E. (1993) Cocaine and benzoylecogonine in saliva, serum and urine, Clinical Chemistry, 39, 481-487.
136. SCHRAMM, W., SMITH, R. H., CRAIG, P. A. & KIDWELL, D. A. (1992) Drugs of abuse in saliva: a review, Journal of Analytical Toxicology, 16, 1-9.
137. SELAVKA, C. M. (1991) Poppy seed ingestion as a contributing factor to opiate-positive urinalysis results: the Pacific Perspective, Journal of Forensic Sciences, 36, 685-696.
138. SIMPSON, D. D. & SAVAGE, L. J. (1980) Treatment re-entry and outcomes of opioid addicts during a four year follow-up after drug abuse treatment in the United States, Bulletin of Narcotics, 32, 1-10.
139. SIMPSON, D., BRAITHWAITE, R. A., JARVIE, D. R. et al. (1997) Screening for drugs of abuse (II): cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs, Annals of Clinical Biochemistry, 34, 460-510.
140. SKOPP, G., POTSCH, L., ESER, H. P. & MOLLER, M. R. (1996) Preliminary practical findings on drug monitoring by a transcutaneous collection device, Journal of Forensic Science, 41, 933-937.
141. SMITH, F. P. & LIU, R. H. (1986) Detection of cocaine metabolite in perspiration stain, menstrual bloodstain and hair, Journal of Forensic Science, 31, 1269.
142. SOARES, J. R., GRANT, J. D. & GOSS, S. J. (1982) Significant developments in radio-immune methods applied to delta 9-THC and its substituted metabolites, in: HAWKS, R. L. (Ed.) The Analysis of Cannabinoids in Biological Fluids, NIDA Research Monographs Series, 42, pp. 44-55 (Rockville, MD, NIDA).
143. STAUB, C. (1993) Hair analysis: its importance for the diagnosis of poisoning associated with opiate addiction, Forensic Science International, 63, 69-75.
144. STEINER, E., VILLEN, T., HALLBERG, M. & RANE, A. (1984) Amphetamine secretion in breast milk, European Journal of Clinical Pharmacology, 27, 123.
145. STILLMAN, R., JONES, R. T., MOORE, D., WALKER, J. & WELM, S. (1993) Improved performance four hours after cocaine, Psychopharmacology, 110, 415-420.
146. STOLK, L. M., COENRADIE, S. M., SMIT, B. J. & VAN-AS, H. L. (1997) Analysis of methadone and its primary metabolite in meconium, Journal of Analytical Toxicology, 21, 154-159.
147. STRANG, J., BLACK, J., MARSH, A. & SMITH, B. (1993) Hair analysis for drugs: technological breakthrough or ethical quagmire (editorial), Addiction, 88, 163-166.
148. TAGLIARO, F., SMYTH, W. F., TURRINA, S., DEYL, Z. & MARIGO, M. (1993) Capillary electrophoresis: a new tool in forensic toxicology. Applications and prospects in hair analysis for illicit drugs, Forensic Science International, 70, 93-104.
149. TRALDI, P., FAVRETTO, D. & TAGLIARO, F. (1993) Ion trap mass spectrometry, a new tool in the investigation of drugs of abuse in hair, Forensic Science International, 63, 239-252.
150. TRNAVSKA, Z., REJHOLEC, V., ELIS, J. & SPICAK, V. (1987) Comparative pharmacokinetic analysis of theophylline in serum and saliva, International Journal of Clinical Pharmacology Research, 7, 329-335.
151. UEMATSU, T. (1992) Establishment of a method to analyse drugs in the hair and its application for determining patient compliance, Nippon Yakurigaku Zasshi, 100, 475-483.
152. VREE, T. B., MUSKENS, A. T. & VAN ROSSUM, J. M. (1972) Excretion of amphetamines in human sweat, Archives of International Pharmacodynamics and Therapeutics, 199, 311.
153. WAINHAUS, S. B., TZANANI, N., DAGAN, S., MILLER, M. L. & AMIRAV, N. (1998) Fast analysis of drugs in a single hair, Journal of the American Society for Mass Spectrometry, 9, 1311-1320.
154. WAN, S. H., MATEN, S. B. & AZARNOFF, D. L. (1978) Kinetics, salivary excretion of amphetamine isomers and effect of salivary pH, Clinical Pharmacology and Therapeutics, 23, 585-590.
155. WANG, W. L. & CONE, E. J. (1995) Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects, Forensic Science International, 70, 39-51.
156. WANG, W. L., DARWIN, W. D. & CONE, E. J. (1994) Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by GC-MS, Journal of Chromatography B: Biomedical Applications, 660, 279-290.
157. WATSON, I. D. (1992) Analysis of commonly abused drugs at selected threshold (cut-off) concentrations, Clinical Chemistry, 38, 441.
158. WELCH, M. J., SNIEGOSKI, L. T., ALLGOOD, C. C. & HABRAM, M. (1993) Hair analysis for drugs of abuse: evaluation of analytical methods, environmental issues, and development of reference materials, Journal of Analytical Toxicology, 17, 389-398.
159. WHITE, K. M., BENJAMIN, W. J. & HILL, R. M. (1993) Human basic tear fluid osomolality. II Importance of processing strategy, Acta Ophthalmology Copenhagen, 71, 530-538.
160. WILSON, J. F., SMITH, B. L., TOSELAND, P. A. et al. (1994) External quality assessment of techniques for the detection of drugs of abuse in urine, Annals of Clinical Biochemistry, 31, 335-342.
161. WINGERT, W. E., FELDMAN, M. S., KIM, M. H., NOBLE, L., HAND, I. & YOON, J. J. (1994) A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy, Journal of Forensic Science, 39, 150-158.
162. WOLFF, K. & HAY, A. W. M. (1994) Plasma methadone monitoring with methadone maintenance treatment, Drug & Alcohol Dependence, 36, 69-71.
163. WOLFF, K., HAY, A. & RAISTRICK, D. (1991) Methadone in saliva, Clinical Chemistry, 37, 1297-1298.
164. WOLFF, K., HAY, A. W. M., RAISTRICK, D. & CALVERT, R. (1993) Steady-state pharmacokinetics of methadone in opioid addicts, European Journal of Clinical Pharmacology, 44, 189-194.
165. WOLFF, K., HAY, A., RAISTRICK, D., CALVERT, R. & FEELY, M. (1992) Measuring compliance in methadone maintenance patients: use of a pharmacologic indicator to "estimate" methadone plasma levels, Clinical Pharmacology & Therapeutics, 50, 199-207.
166. WOLFF, K., ROSTAMI-HODJEGAN, A., SHIRES, S. et al. (1997) The pharmacokinetics of methadone in healthy subjects and opiate users, British Journal of Clinical Pharmacology, 44, 325-334.
167. WOLFF, K., SANDERSON, M., HAY, A. W. M. & RAISTRICK, D. (1991) Methadone concentrations in plasma and their relationship to drug dosage, Clinical Chemistry, 37, 205-209.
168. WOLFF, K., WELCH, S. & STRANG, J. (1999) Specific laboratory investigations for assessments and management of drug problems, Advances in Psychiatric Treatment, 5, 180-191.
169. WORLD HEALTH ORGANIZATION (1992) The ICD-10 Classification of Mental and Behavioural Disorders (Geneva, WHO).
170. WU, A. H., OSTHEIMER, D., CREMESE, M., FORTE, E. & HILL, D. (1994) Characterisation of drug differences caused by coelution of substances in gas chromatography/mass spectrometry confirmation of targeted drugs in full-scan and selected-ion monitoring modes, Clinical Chemistry, 40, 216-220.